in a 6-week study of children and adolescents with attention deficit disorder with hyperactivity ( addh ) in which desipramine ( dmi ) was highly effective and well tolerated , the mean maximal daily oral dose in the dmi-treated patients ( n = 31 ) was 4.6 +/- 0.2 mg/kg .
C1263846
with attention deficit disorder
C0011685
desipramine